International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia.
暂无分享，去创建一个
M. Gobbi | R. Hills | F. Giles | A. Gianella-Borradori | J. Altman | N. Vey | G. Roboz | M. Arellano | A. Pigneux | S. Solomon | C. O'Connell | P. Montesinos | T. Rosenblat | T. F. Jacobsen | ØivindK. Foss | Sylvia Vetrhusand